Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway

Small cell lung carcinoma (SCLC) is considered one of the most aggressive types of lung cancer due to its rapid growth and early metastasis. No tumor markers or therapeutic targets have been demonstrated to be specific or effective in SCLC to date. This study aims to evaluate the potential of Flotillin1 (Flot1) as a target of SCLC treatment.Flot1 expression level in the tissue of SCLC and other tissue of lung disease was detected using...